GR144053, a fibrinogen receptor antagonist, enhances the suppression of neointima formation by losartan, an angiotensin II receptor antagonist, in the injured carotid artery of hamster

British Journal of Pharmacology

Volumn 122, Issue 6, 1997, Pages 1099-1104

  Matsuno, Hiroyuki ^a   Kozawa, Osamu ^a   Niwa, Masayuki ^a   Kaida, Takehiro ^a   Hayashi, Hideharu ^b   Uematsu, Toshihiko ^a  

^a GIFU UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AT1 antagonist; Combined therapy; Fibrinogen receptor antagonist; Neointima formation; SMC proliferation

Indexed keywords

4 [4 [4 (AMINOIMINOMETHYL)PHENYL] 1 PIPERAZINYL] 1 PIPERIDINEACETIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BROXURIDINE; FIBRINOGEN RECEPTOR ANTAGONIST; LOSARTAN;

ANIMAL EXPERIMENT; ARTERY INJURY; ARTERY INTIMA; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; HAMSTER; MALE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CAROTID ARTERIES; CELL DIVISION; CRICETINAE; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; LOSARTAN; MALE; PIPERAZINES; PIPERIDINES; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECEPTORS, ANGIOTENSIN;

EID: 0030781335     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701500     Document Type: Article

References (26)

1. ASSOIAN, R.K., GROTENDORST, G.R., MILLER, D.M. & SPORN, M.B. (1984). Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature, 309, 804-806.
2. AZUMA, H., NIIMI, Y. & HAMASAKI, H. (1992). Prevention of intimal thickening after endothelial removal by a nonpeptide angiotensin II receptor antagonist, losartan. Br. J. Pharmacol., 106, 665-671.
3. CASSCELLS, W. (1992). Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation, 86, 723-729.
4. COLLER, B.S., FOLTS, J.D., SCUDDER, L.E. & SMITH, S.R. (1986). Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model. Blood, 68, 783-786.
5. CLOZEL, J.P., MULLER, R.K., ROUX, S., FISCHLI, W. & BAUMGARTNER, H.R. (1993). Influence of the status of the renin-angiotensin system on the effect of cilazapril on neointima formation after vascular injury in rats. Circulation, 88, 1222-1227.
6. DAVID, P. & FAXON, M.D. MARCATOR STUDY GROUP. (1995). Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MERCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril. J. Am. Coll. Cardiol., 25, 362-369.
7. DETRE, K., HOLUBKOV, R., KELSEY, S., COWLEY, M., KENT, K., WILLIAMS, D., MYLER, R., FAXON, D., HOLMES, D. Jr, & BOURASSA, M. (1988). Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. N. Eng. J. Med., 318, 265-270.
8. FERNS, G.A., RAINS, E.W., SPRUGEL, K.H., MOTANI, A.S., REIDY, M.A. & ROSS, R. (1991). Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science, 253, 1129-1132.
9. GIBBONS, G.H., PRATT, R.E. & DZAU, V.J. (1992). Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J. Clin. Invest., 90, 456-461.
10. ITOH, H., MUKOYAMA, M., PRATT, R.E., GIBBONS, G.H. & DZAU, V.J. (1993). Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J. Clin. Invest., 91, 2268-2274.
11. KAIDA, T., MATSUNO, H., NIWA, M., KOZAWA, O., MIYATA, H. & UEMATSU, T. (1997). Antiplatelet effect of FK633, a platelet glycoprotein IIb/IIIa antagonist, on thrombus formation and vascular patency after thrombolysis in the injured hamster carotid artery. Thromb. Haemost., 77, 562-567.
12. KAWASAKI, T., SAKAI, Y., TANIUCHI, Y., SATO, K., MARUYAMA, K., SHIMIZU, M., KAKU, S., YANO, S., INAGAKI, O., TOMIOKA, K., YANAGISAWA, I. & TAKENAKA, T. (1996). Biochemical characterization of a new disintegrin flavostatin, isolated from Trimeresurus flavoviridis venom. Biochimie, 78, 245-252.
13. KISS, R.G., STASSEN, J.M., DECKMYN, H., ROSKAMS, T., GOLD, H.K., PLOW, E.F. & COLLEN, D. (1994). Contribution of platelets and the vessel wall to the antithrombotic effects of a single bolus injection of Fab fragments of the antiplatelet GPIIb/IIIa antibody 7E3 in a canine arterial eversion graft preparation. Arterioscler. Throm., 14, 375-380.
14. KOHMURA, C., GOLD, H.K., YASUDA, T., HOLT, R., NEDELMAN, M.A., GUERRERO, J.L., WEISMAN, H.F. & COLLEN, D. (1993). A chimeric murine/human antibody Fab fragment directed against the platelet GPIIb/IIIa receptor enhances and sustains arterial thrombolysis with recombinant tissue-type plasminogen activator in baboons. Arterioscler. Thromb., 13, 1837-1842.
15. KONSTANTOPOULOS, K., KAMAT, S.G., SCHAFER, A.I., BANEZ, E.J., JORDAN, R., KLEIMAN, N.S. & HELLUMS, J.D. (1995). Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3Fab, in patients undergoing coronary angioplasty. Circulation, 91, 1427-1431.
16. LINDNER, V., OLSON, N.E., CLOWES, A.W. & REIDY, M.A. (1992). Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor. J. Clin. Invest., 90, 2044-2049.
17. LINZ, W., WIEMER, G., GOHLKE, P., UNGER, T. & SCHOLKENS, B.A. (1995). Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol. Rev., 47, 25-49.
18. LIU, M.W., ROUBIN, G.S., ROBINSON, K.A., BLACK, A.J., HEARN, J.A. & SIEGEL, R.J. (1990). Trapidil in preventing restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation, 81, 1089-1093.
19. MATSUNO, H., STASSEN, J.M., HOYLAERTS, M.F., VERMYLEN, J. & DECKMYN, H. (1995). Fast and reproducible vascular neointima formation in the hamster carotid artery: effects of trapdil and captopril. Thromb. Haemost., 74, 1591-1596.
20. MATSUNO, H., STASSEN, J.M., VERMYLEN, J. & DECKMYN, H. (1994). Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation, 90, 2203-2206.
21. NICHOLAS, B. & LUMLEY, P. (1995). Uptake of a fibrinogen receptor antagonist by human platelets appears dependent upon GPIIb/IIIa. Thromb. Haemost., 73, (Suppl) 1130.
22. PEERLINCK, DE LEPELEIRE, I., GOLDBERG, M., FARRELL, D., BARRETT, J., HAND, E., PANEBIANCO, D., DECKMYN, H., VERMYLEN, J. & ARNOUT, J. (1993). MK-383 (L-700, 462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man. Circulation, 88, 1512-1517.
23. PRESCOTT, M.F., WEBB, R.L. & REIDY, M.A. (1991). Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am. J. Pathol., 139, 1291-1296.
24. RAKUGI, H., WANG, D.S., DZAU, V.J. & PRATT, R.E. (1994). Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation, 90, 449-455.
25. SERRUYS, P.W., LUIJTEN, H.E., BEATT, K.J., GEUSKENS, R., DE FEYTER, P.J., VAN DEN BRAND, M., REIBER, J.H., TEN KATEN, H.J. & VAN ES, G.A. (1988). Hugenholtz PG. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation, 77, 361-371.
26. SIMONS, M., EDELMAN, E.R., DEKEYSER, J.L., LANGER, R. & ROSENBERG, R.D. (1992). Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature, 359, 67-70.